Health
Study suggests a new way to personalize anti-CTLA-4 therapy for cancers – News-Medical.Net
A Ludwig Cancer Research study has identified a novel mechanism by which a type of cancer immunotherapy known as CTLA-4 blockade can disable suppressive immune…
A Ludwig Cancer Research study has identified a novel mechanism by which a type of cancer immunotherapy known as CTLA-4 blockade can disable suppressive immune cells to aid the destruction of certain tumors. The tumors in question are relatively less reliant on burning sugar through a biochemical process known as glycolysis.
Researchers led by Taha Merghoub and Jedd Wolchok of the Ludwig Center at Memorial Sloan Kettering Cancer Center (MSK) and former postdoc Roberta Zappasodi-;now at Weill Cornell…
-
General24 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
General22 hours agoEveryday AI use brings a hidden climate cost
-
Noosa News17 hours agoThe Laundry Lady secures $1M to fuel international expansion
-
Noosa News14 hours agoTruffle growers say rare delicacy is worth its $3,500 per kilo expense